Fangtian Fan

945 citations
44 papers · 760 indexed · h-index 18
Topics
Lung Cancer Treatments and Mutations (9 papers)Cancer, Hypoxia, and Metabolism (7 papers)RNA modifications and cancer (6 papers)
Partner nations
ChinaUnited States

In The Last Decade

Fangtian Fan

42 papers receiving 755 citations

Peers

Fangtian Fan
Comparison fields: 5 of 86
  • Molecular Biology 414
  • Cancer Research 192
  • Oncology 142
  • Pulmonary and Respiratory Medicine 115
  • Complementary and alternative medicine 69
Replace Shravanti Mukherjee with:
Shravanti Mukherjee India
Tae‐Hwe Heo South Korea
Aamer Qazi United States
Bano Shabnam India
Xiangzhong Zhao China
Nehal Gupta United States
Yizeng Fan China
Veronica Cocetta Italy
Nina Xue China
Fangtian Fan relative to Shravanti Mukherjee India Shravanti Mukherjee's profile →
Citations per field
00.5×1.5×2.4×
Shravanti Mukherjee · 1×
Citations per year

Countries citing papers authored by Fangtian Fan

Since Specialization
Citations

This map shows the geographic impact of Fangtian Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangtian Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangtian Fan more than expected).

Fields of papers citing papers by Fangtian Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangtian Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangtian Fan. The network helps show where Fangtian Fan may publish in the future.

Co-authorship network of co-authors of Fangtian Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Fangtian Fan. A scholar is included among the top collaborators of Fangtian Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangtian Fan. Fangtian Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 0
4 1
5 10
6 7
7 5
8 8
9 14
10 4
11 15
12 33
13 20
14 19
15 15
16 10
17 40
18 51
19 16
20 70

About Fangtian Fan

Fangtian Fan is a scholar working on Cancer Research, Complementary and alternative medicine and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 760 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Cancer, Hypoxia, and Metabolism (7 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (192 citations), Complementary and alternative medicine (69 citations) and Pharmacology (68 citations). Fangtian Fan has collaborated with scholars based in China and United States. Frequent co-authors include Aiyun Wang, Hongyan Wu, Yin Lu, Zhaoguo Liu, Shizhong Zheng, Cunsi Shen, Liwei He, Tao Li, Junshan Ruan and Yuping Liu. Their work appears in journals such as PLoS ONE, Journal of Ethnopharmacology and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026